Insurance

Strategies for Implementing Best Practices in Independent Physician Associations

June 16th 2020, 8:00pm

The objective of this research was to identify strategies that significantly lower unnecessary inpatient utilization among Medicare beneficiaries with chronic disease.

Dr Robert Gabbay Reflects on Insulin Cost Caps for Some Medicare Beneficiaries

June 14th 2020, 4:00pm

Video

The announcement of a $35 per month out-of-pocket cap for insulin for some individuals with Medicare is a real victory for the American Diabetes Association and for people with diabetes, said Robert Gabbay, MD, PhD, chief medical and scientific officer of the American Diabetes Association.

AJMC® in the Press, June 12, 2020

June 12th 2020, 7:18pm

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Medicare Diabetes Prevention Program: Where Are the Suppliers?

June 12th 2020, 5:00pm

Article

Despite the Medicare Diabetes Prevention Program now being a covered benefit, there is inadequate availability of suppliers to reach Medicare beneficiaries with prediabetes.

Racial Disparities Shift in Observation Status in Hospital Admissions for Avoidable Conditions

June 2nd 2020, 4:16am

Article

A study released Monday used national Medicare data to try and understand disparities between black and white patients in avoidable hospitalizations for ambulatory care–sensitive conditions.

How Comorbidities Affect Costs and Costs Impact Nonadherence in RA

May 29th 2020, 8:26pm

Article

For patients with rheumatoid arthritis (RA), cost can play a role in patient adherence to medication, but the presence of comorbidities does not impact cost of care for patients, according to 2 abstracts presented at the Virtual 2020 International Society for Pharmacoeconomics and Outcomes Research meeting.

This Week in Managed Care: May 29, 2020

May 29th 2020, 5:00pm

Video

This week, the top managed care news included lower insulin costs for seniors in certain plans; discussions on the future of the Biologics Price Competition and Innovation Act; takeaways from Sharecare's Flatten the Curve Survey.

Seniors in Certain Part D Plans, Medicare Advantage to See Insulin Costs Capped in 2021

May 26th 2020, 9:52pm

Article

President Trump announced the plan today at the White House, accompanied by insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, as well as AHIP and major health plans.

Examining the Links Among Diabetes Education, Activity, and Food Insecurity

May 24th 2020, 4:00pm

Article

The presentation at Virtual ISPOR 2020 found that 7% of a group of Medicare beneficiaries with type 2 diabetes was experiencing food insecurity, a rate the lead author found "alarming."

Early Detection Programs May Help Offset Costs of COPD Exacerbations, Studies Find

May 21st 2020, 9:00pm

Article

Exacerbations of patients with chronic obstructive pulmonary disorder (COPD) can be costly if they are frequent, and early detection programs for COPD may help offset these costs, according to research from 2 studies presented at the 2020 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) virtual conference.